Hungarian GEnomic Research on pathogenic Microbes Hu-GERM.

Slides:

Advertisements

Similar presentations

UCSF and Global Health Institutional Infrastructure for Global Health Projects Role of Surgery and Global Health Future Opportunities and Research.

Advertisements

Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology.

Microbial Genetics Chapter 9 (p ) Copyright © The McGraw-Hill Companies, Inc) Permission required for reproduction or display.

Characterizing Uncultured Bacteria Michael Wagner Division of Microbial Ecology University of Vienna.

Antimicrobial Resistance Surveillance Latin America

Goals of PATHOGENOMICS related research Chief Scientist Office Ministry of Health Israel.

1.Your name 2.Why are you enrolled in General Microbiology? 3.How many pets do you have and what are their names? 4.What is your favorite type of food?

PATHOGENOMIC RESEARCH IN HUNGARY PRESENT STAGE AND PERSPECTIVES Ideas for cooperation L. Emődy - B. Nagy ERE-NET PathoGenoMics Meeting Bonn, April,

Medical Diagnostics NIAID Funding Opportunities Maria Y. Giovanni, Ph.D. Assistant Director for Microbial Genomics and Advanced Technologies National Institute.

Pathogenomics: Focusing studies of bacterial pathogenicity through evolutionary analysis of genomes.

Food Microbiology 08/11/11.

Your Body Is an Ecosystem By: Malissa Northup, M.Ed. Weymouth High School Summer 2010 Workshop in Biology and Multimedia for High School Teachers Background.

1. How does conjugation work? Sex in Bacteria How do bacteria exchange DNA.

Regulation of Virulence Genes Salyers & Whitt: Bacterial Pathogenesis: A Molecular Approach ASM Press, 1994 Dorman, C.J: Genetics of Bacterial Virulence.

Aynaz Taheri 1 C. Gyles and P. Boerlin. * Transfer of foreign DNA * Mechanisms of transfer of DNA * Mobile genetic elements (MGE) * MGEs in the virulence.

Microbial growth and metabolism: In Medical Microbiology, microbial cultivation is required for the following purposes: In Medicine: 1-Diagnosis of most.

Microbial Genetics Mutation Genetic Recombination Model organism

Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.

Development of new tools to study the cell biology and origins of phenotypic variation in the human pathogen Streptococcus pneumoniae: An overview of recently.

BIO 411 – Medical Microbiology Chapter 9 Commensal and Pathogenic Microbial Flora.

Genetic transfer and recombination

Sequencing capacitiesacademic company based microarray facilitiesacademic company based bioinformaticsacademic proteomic facilitiesacedemic Genome Research.

FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.

CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.

MDR Organisms in Holy Family Hospital Rawalpindi

Pathogen Biology & Translational Medicine Wellcome Trust Centre for Human Genetics International Scientific Advisory Board Tuesday 15 th February 2011.

ERA-NET PathoGenoMics Meeting Bonn 7-8 April, 2005 Research topics of interest in the Area of Genomics of Bacterial and Fungal Pathogens of Humans Prof.

GENOME SEQUENCING AND FUNCTIONAL GENOMICS NATIONAL PROGRAM IN LATVIA AND ERA-NET “PATHOGENOMICS” Viesturs Baumanis, Latvian Council of Science Berlin,

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.

Escherichia coli O157:H7 and Shiga toxin-converting bacteriophage Edward G. Dudley, Ph.D Department of Food Science

Antimicrobial Stewardship

MICROBES AND MAN Research Programme October 13, 2004 Berlin Soile Juuti Programme manager Finland.

WP3 Strategic analysis of the future perspectives for cooperation and coordination Summary of the expert workshop on the European Research Agenda (WP 3)

Laboratory of Enteric and Sexually Transmitted Diseases Historical Perspective Origin: Began in Established to review the rapidly increasing.

P ATHO G ENO M ICS PORTUGAL Partner 9 P ATHO G ENO M ICS PORTUGAL Partner 9.

Host-Parasite Relationship Normal Flora Pathogens Infections Opportunistic pathogens.

Science Starter: How do Fossil Records show evidence for Evolution?

Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA.

Small Talk Cell-to-Cell Communication in Bacteria.

Ministry of Education, Science and Sport Republic of Slovenia Ministry of Education, Science and Sport Republic of Slovenia Research in Slovenia Dr. Livija.

ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.

Molecular Techniques in Microbiology These include 9 techniques (1) Standard polymerase chain reaction Kary Mullis invented the PCR in 1983 (USA)Kary.

Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.

Ecology, evolution, and antibiotic resistance Carl T. Bergstrom Department of Biology University of Washington University of Michigan December 8th, 2005.

1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.

Lab 13 Microbial Control with Chemical Agents. Staphylococcus aureus Escherichia coli Do all disinfectants and antiseptics work equally well against.

Pathogenomics How this project began: Ann Rose - take advantage of DNA sequence information - genomics Julian Davies - use the information to understand.

Your Immune System  J 1. AIDS is a disease that destroys the immune system.  H 2. Pathogens are disease-causing bacteria.  D3. Mucus traps pathogens.

Introductory medical bacteriology Chien-Ming Li MD, Ph.D.

Points for Discussion Anti-Infective Drugs Advisory Committee Meeting March 5, 2003.

Pathogenicity of Bacteria. Campylobacter spp. Salmonella spp. Escherichia coli 76 Million Cases of Food-borne illness every year in the USA 325,000 result.

Commensal and Pathogenic Microbial Flora in Humans

GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.

Production of variation Selection for/against  Pop evolves:  cumulative change in heritable characteristics in population  Nat sel can act on pop w/o.

The rate of evolution Where selection pressures are high, the rate of evolution can be rapid.

Genome sequencing of disease causing microorganism Romana Siddique.

Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage.

Microbial growth and metabolism:

Department of Immunochemistry of Glycoconjugates

Prof. Ramesh Wigneshweraraj

Summary of WHO PPL, CDC, and ESKAPE pathogen lists

Antimicrobial Resistance: Plans for Korea and Beyond

Genomics of epidemic pathogens

C.J. Dorman Clinical Microbiology and Infection

Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay for the rapid identification of bacterial pathogens Y. Wang, F. Kong, G.L.

Non-antibiotic strategies for sepsis

Summary of WHO PPL, CDC, and ESKAPE pathogen lists

A. Oliver, A. Mena Clinical Microbiology and Infection

S. Borrell, S. Gagneux Clinical Microbiology and Infection

Myron Christodoulides

Presentation transcript:

Hungarian GEnomic Research on pathogenic Microbes Hu-GERM

Centers of pahogenomic research of Hungary

Funding Agencies of Hu-GERM OTKA (Hungarian Scientific Research Fund) : HAS (Hungarian Academic Society) : - Invites applications on different research fields - Annual research funding 20 million Euro - Microbial pathogenomic research Euro ETT (Medical Research Council) : - Coordinates scientific research in Hungary - the owner of 46 research institutes in the country on different fields - supports research by inviting applications

Running projects of Hu-GERM (2005) Studied microbes: Bacteroides spp. Chlamydia pneumoniae Clostridium difficile Enterococcus Escherichia coli Helicobacter pylori Mycobacteria Pseudomonas aeruginosa Salmonella Staphylococcus Streptococcus Yersinia

Topics of the 14 running projects of Hu-GERM supported by OTKA I. Attenuation of Escherichia coli by global regulatory mutations. (Emődy L.) Investigations on the pathogenicity of enteroinvasive bacteria. (Pál T.) Investigations with a regulatory mutant vaccine candidate Salmonella enterica strain eliciting cross-immunity in mice. (Nagy G.) The role of horizontal gene transfer in the evolution of enterotoxic and cytotoxic Escherichia coli bacteria. (Nagy B.) Occurence in Hungary, and molecular biological characterization of cytolethal distending toxin (CDT), a new cytotoxin.(Tóth I.) Investigations on genome-evolution and plasticity by genome reduction. (Pósfai G.) Investigations on the mechanism of human enterobacterial infections. (Győrffy Z.)

Topics of the 14 running projects of Hu-GERM supported by OTKA II. Multi-drug resistence types in Pseudomonas aeruginosa. (Szabó D.) In vitro and in vivo pathogenomic studies on methicillin resistant and methicillin sensitive Staphylococcus aureus strains. (Rozgonyi F.) Molecular biological studies on virulence factors of bacteria causing anaerobic infections. (Nagy E.) Cytokine gene polymorphism in diseases of microbial and complex origin. (Mándi Y.) Reactivation of mycobacteria. (Miczák. A.) Genetic background of the relationship between atherosclerosis and Chlamydia pneumoniae. (Gönczöl É.)

Objectives of Hu-GERM - Enhance collaboration among research groups. - Upgrade the infrastructure of pathogenomic research in Hungary. - Participation in the European ERANET-Pathogenomics Network